miR-301a as an NF-κB activator in pancreatic cancer cells.
about
A miR-19 regulon that controls NF-κB signalingMicroRNAs in NF-kappaB signalingResolution of Inflammation: What Controls Its Onset?Subclinical Detection of Diabetic Cardiomyopathy with MicroRNAs: Challenges and PerspectivesInsect microRNAs: biogenesis, expression profiling and biological functionsCritical role of NF-κB in pancreatic cancerMicroRNAs: new regulators of Toll-like receptor signalling pathwaysMicroRNA and signal transduction pathways in tumor radiation responseDissecting the expression landscape of RNA-binding proteins in human cancersAltered microRNA signatures in sputum of patients with active pulmonary tuberculosis.MicroRNA regulation of innate immune responses in epithelial cellsThe expression and functions of microRNAs in pancreatic adenocarcinoma and hepatocellular carcinomaInflammation to cancer: The molecular biology in the pancreas (Review).Targeting miRNAs for pancreatic cancer therapyHERG1 functions as an oncogene in pancreatic cancer and is downregulated by miR-96.N-methylnicotinamide and nicotinamide N-methyltransferase are associated with microRNA-1291-altered pancreatic carcinoma cell metabolome and suppressed tumorigenesis.The oncogenic role of microRNA-130a/301a/454 in human colorectal cancer via targeting Smad4 expressionDown-regulation of BTG1 by miR-454-3p enhances cellular radiosensitivity in renal carcinoma cells.miR-524-5p suppresses the growth of oncogenic BRAF melanoma by targeting BRAF and ERK2.MicroRNA-301a mediated regulation of Kv4.2 in diabetes: identification of key modulators.The role of miR-200a in mammalian epithelial cell transformation.MicroRNA-301a promotes migration and invasion by targeting TGFBR2 in human colorectal cancer.NF-κB and cancer: a paradigm of Yin-Yang.Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits Pparγ expression and promotes pancreatic cancer progression in mice.Circulating microRNAs are promising novel biomarkers for drug-resistant epilepsyClinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.MicroRNA-26b inhibits cell proliferation and cytokine secretion in human RASF cells via the Wnt/GSK-3β/β-catenin pathway.A potent 2'-O-methylated RNA-based microRNA inhibitor with unique secondary structures.Regulation of Nuclear Receptor Nur77 by miR-124.The activity of Gli transcription factors is essential for Kras-induced pancreatic tumorigenesis.MicroRNA-301a regulation of a T-helper 17 immune response controls autoimmune demyelinationMicroRNA-19a mediates gastric carcinoma cell proliferation through the activation of nuclear factor-κB.miRNA-26b Overexpression in Ulcerative Colitis-associated Carcinogenesis.Transcriptional regulation of microRNA-100, -146a, and -150 genes by p53 and NFκB p65/RelA in mouse striatal STHdh(Q7)/ Hdh(Q7) cells and human cervical carcinoma HeLa cells.Hsa-miR-301a-3p Acts as an Oncogene in Laryngeal Squamous Cell Carcinoma via Target Regulation of Smad4MicroRNA-26b Modulates the NF-κB Pathway in Alveolar Macrophages by Regulating PTEN.Manganese superoxide dismutase expression is negatively associated with microRNA-301a in human pancreatic ductal adenocarcinoma.MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4.A statin-regulated microRNA represses human c-Myc expression and function.A functional genomics screen for microRNA regulators of NF-kappaB signaling.
P2860
Q24602478-7A79EE56-630B-42C9-8C6D-AF3AFA18D716Q24630097-68DC17B0-D122-4C5D-9105-1B5A09201ADDQ26747410-0EE818D7-B9CA-4867-B3A4-A1B4B5938D8AQ26771750-6F90A007-C84B-4485-9916-E8B6D6ED9A21Q26829772-49FF4531-FF4E-497A-BCF1-669D9662DB24Q26864198-FEB1E630-EB20-4728-866B-CE2657A42D0BQ27010055-DA762B3F-2E5C-4299-82D7-9D68594D54C2Q27027546-559A5E29-81AA-420D-B4C8-20308E96ED0AQ28305624-D0BDBD5E-B3A9-4044-B6FB-1E8B460B257CQ31086074-655E5490-EACF-4A0C-A3E3-43C8F6A4B4CBQ33577518-B67560B2-2200-4C07-9CD9-AF6330AB4A6FQ33579675-E2D4B84F-9E0F-4E4A-927A-51B874F9761BQ33727657-0AF57B20-A56F-4786-B45E-7301CF587C8DQ33962488-C47ADE7D-2EA7-47AA-B3D7-95E4ACC46E64Q34221680-EC12CA84-35F1-4F45-91BE-DA20241DF5B1Q34260260-D94957F9-FFE2-4DA2-950B-23633ED7E6E3Q34326881-284B50D0-67A7-483D-ABC2-6BFE0D86748DQ34611989-6B62065E-8A7D-4984-871A-1EEF97301263Q34619395-89F892AF-DC78-4538-B7DB-B3CCE70EE369Q34662020-8A13A056-7DFA-4966-BD85-7193581D7B34Q34917932-2C739206-5FC0-47E9-9E48-9731DF94E729Q35005275-9F41DFC4-2211-47F7-9993-F67B5F7571EEQ35232248-795065D6-A67A-4FE0-87DC-786100C630C9Q35578568-859B9AE7-41C8-4428-B9FF-C63250C483E2Q35617456-5259D102-B394-43BB-840D-3BD9D826BADDQ35735278-396B0A9C-0330-4C46-BFAA-8994D9D70355Q35755282-DC0B47E3-4900-47A0-90A3-7C836E58AC61Q35906150-1E91EC46-9210-4F40-9441-34A063E36E10Q35913193-C103A807-4248-49E2-89F3-8A73E4FF99C2Q35921887-4F1219B7-B3B7-4578-BA66-9864ED6EE1E7Q35974243-222800D4-FF77-427F-B8BE-DDF2A7E3772CQ36089724-D27EF061-114A-4AD6-884B-9D258DE7DE68Q36155971-13F45735-E828-4E3E-BCFF-7F49CF6C968EQ36190256-FB1AE502-6609-4BC6-B9E7-7231301F132FQ36275017-D31723EF-A7BA-4C64-8510-4F7BC14F9A4CQ36304803-84DC9972-3CED-46D3-962C-1C78836B6C31Q36347993-06D9AAE1-D47B-42B5-BFE2-B73A5CD38B7BQ36356232-3263F9FC-359B-4255-946D-3CC72061BAF8Q36379501-3A59C42F-BEEF-44BD-88B0-11CBF8639B5AQ36753727-D5DF050D-9E4B-4A55-A6F4-2C48C86BB681
P2860
miR-301a as an NF-κB activator in pancreatic cancer cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
miR-301a as an NF-κB activator in pancreatic cancer cells.
@ast
miR-301a as an NF-κB activator in pancreatic cancer cells.
@en
miR-301a as an NF-κB activator in pancreatic cancer cells.
@nl
type
label
miR-301a as an NF-κB activator in pancreatic cancer cells.
@ast
miR-301a as an NF-κB activator in pancreatic cancer cells.
@en
miR-301a as an NF-κB activator in pancreatic cancer cells.
@nl
prefLabel
miR-301a as an NF-κB activator in pancreatic cancer cells.
@ast
miR-301a as an NF-κB activator in pancreatic cancer cells.
@en
miR-301a as an NF-κB activator in pancreatic cancer cells.
@nl
P2093
P2860
P356
P1433
P1476
miR-301a as an NF-κB activator in pancreatic cancer cells.
@en
P2093
Apana Takwi
Daniel J Conklin
Jingwen Zhang
Ken H Young
Robert Martin
Zhongxin Lu
P2860
P356
10.1038/EMBOJ.2010.296
P407
P577
2010-11-26T00:00:00Z